Compounds > bicalutamide

bicalutamide and Cancer of Parotid

bicalutamide has been researched along with Cancer of Parotid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalgleish, AG; Di Palma, S; Fusi, A; Nathan, K; Patel, N; Powell, B1
Bossi, P; Cantù, G; Licitra, L; Locati, LD; Marchianò, AV; Quattrone, P1

Other Studies

2 other study(ies) available for bicalutamide and Cancer of Parotid

ArticleYear
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.
    European journal of cancer (Oxford, England : 1990), 2019, Volume: 113

    Topics: Adenocarcinoma; Adult; Aged; Androgen Receptor Antagonists; Androstenes; Anilides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Cancer Vaccines; Humans; Male; Nitriles; Parotid Neoplasms; Receptors, Androgen; Tosyl Compounds

2019
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Parotid Gland; Parotid Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; Risk Assessment; Skin Ulcer; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2003